Full history for every metric is available with a Kvantra account
AfroCentric Investment Corporation Limited (ACT.JO)
Key financial summary
Financials in ZAR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | ZAR m | 8,074 | 8,723 | 8,760 | 8,795 | 8,503 | 7,303 | 7,303 |
| Operating profit | ZAR m | 159 | 159 | |||||
| Net profit | ZAR m | 302 | 313 | 184 | 55 | -29 | -1,274 | -1,274 |
| EPS reported | ZAR | -1.52 | -1.52 | |||||
| Operating cashflow per share | ZAR | 0.81 | 0.81 | |||||
| Capex per share | ZAR | 0.26 | 0.26 | |||||
| FCF per share | ZAR | 0.55 | 0.55 | |||||
| Free cash flow | ZAR m | 466 | 466 | |||||
| Net debt | ZAR m | -10 | -10 | |||||
| Book value equity | ZAR m | 1,903 | 1,903 | |||||
| Book value per share | ZAR | 2.23 | 2.23 | |||||
| Number of shares | m | 852.81 | 852.81 | |||||
| DPS (TTM paid) | ZAR | 0.00 | 0.00 |
Financial summary
Financials in ZAR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 0.59 | 0.32 | |||||
| P/S LTM | x | 0.15 | 0.08 | |||||
| P/FCF LTM | x | 2.40 | 1.30 | |||||
| EV/EBITDA LTM | x | -19.67 | -9.34 | |||||
| EV/Sales LTM | x | 0.17 | 0.08 | |||||
| Earnings Yield LTM | % | -113.95% | -204.81% | |||||
| FCF Yield | % | 41.63% | 76.85% | |||||
| Quality | ||||||||
| ROE | % | -66.97% | -66.97% | |||||
| ROIC | % | 5.43% | 5.43% | |||||
| Operating margin | % | 2.18% | 2.18% | |||||
| Gross margin | % | 65.46% | 65.46% | |||||
| FCF/Sales | % | 6.37% | 6.37% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -14.11% | -14.11% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | +57.89% | +57.89% | |||||
| Operating Profit Growth | % | -76.42% | -76.42% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 4.51% | 0.00% | |||||
| Dividend Growth | % | -100.00% | -100.00% | |||||
| Payout Ratio | % | 0.00% | -3.96% | |||||
| FCF/Debt | x | 0.63 | 0.63 | |||||
| Net Debt/EBITDA | x | -2.14 | -2.14 | |||||
| EBIT/Net interest | x | 2.11 | 2.11 | |||||
| Net debt/market cap | % | -0.88% | -1.63% | |||||
| Net debt/Equity | x | -0.01 | -0.01 | |||||
| Gross debt/equity | x | 0.39 | 0.39 | |||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
AfroCentric Investment Corporation Limited, an investment holding firm established in 2008 and headquartered in Roodepoort, South Africa, focuses on providing comprehensive health administration and risk management solutions to the healthcare industry. The company operates through several key segments: Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology. Its diverse service portfolio includes supplying documentation-based care equipment and administrative support to 12 musculoskeletal treatment centers. Additionally, AfroCentric manages the retail and wholesale distribution of pharmaceutical products through brands such as Pharmacy Direct, MMed, Scriptpharm Risk Management, Curasana Wholesaler, and Activo Health. The corporation also offers vital management solutions for HIV and other health conditions. Its geographical reach extends across South Africa, Botswana, Mauritius, Namibia, Eswatini, and Zimbabwe.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
AfroCentric Investment Corporation Limited (ACT.JO)
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
AfroCentric Investment Corporation Limited, an investment holding firm established in 2008 and headquartered in Roodepoort, South Africa, focuses on providing comprehensive health administration and risk management solutions to the healthcare industry. The company operates through several key segments: Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology. Its diverse service portfolio includes supplying documentation-based care equipment and administrative support to 12 musculoskeletal treatment centers. Additionally, AfroCentric manages the retail and wholesale distribution of pharmaceutical products through brands such as Pharmacy Direct, MMed, Scriptpharm Risk Management, Curasana Wholesaler, and Activo Health. The corporation also offers vital management solutions for HIV and other health conditions. Its geographical reach extends across South Africa, Botswana, Mauritius, Namibia, Eswatini, and Zimbabwe.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free